KCL-286 | MedChemExpress (MCE)
Anticancer agent 168 is an orally active retinoic acid receptor (RAR/RXR) beta2 agonist with ameliorating effects on spinal cord injury (SCI)[1].
| Trivial name | KCL-286 |
| Catalog Number | HY-111573 |
| Research Area | Others |
| CAS# | 1952276-71-9 |
| Purity | ≥98.00% |
| SMILES | CC1=CC=C(C)C2=C1OC(C3=NC(C4=CC=C(C(O)=O)C=C4)=NO3)=C2 |
| PubChem Chemical Structure ID | 121414283 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/anticancer-agent-168.html |